#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Thrombocytopenia is a condition in which there are too few platelets, the blood cells that prevent bleeding. Many things can cause thrombocytopenia in children, most commonly infections (especially viral infections) and destruction of platelets by the immune system (called immune thrombocytopenia or ITP). Children with thrombocytopenia may also have lower numbers of other blood cell types, such as red and white blood cells, depending on the cause.
Without enough platelets, a child may bleed more easily, including:
Excessive bleeding, or hemorrhage, can be dangerous and affect the brain or major body functions.
Children and teens with thrombocytopenia are treated through the Blood Disorders Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children's Hospital – and a world leader in the treatment and research of all types of pediatric blood disorders.
Learn more about thrombocytopenia on the Dana-Farber/Boston Children's website.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”